نتایج جستجو برای: hydrochlorothiazide

تعداد نتایج: 2020  

2015
Eliska Vaculikova Daniela Placha Martin Pisarcik Josef Jampilek

Aqueous solubility and permeability through biomembranes are important parameters for drug bioavailability. Nanoparticles can be considered as a useful tool for improving properties of poorly soluble and/or permeable active ingredients. Hydrochlorothiazide (Class IV of BCS) was chosen as a model compound. Antisolvent precipitation – solvent evaporation and emulsion solvent evaporation methods w...

Journal: :Universal journal of pharmaceutical research 2023

Background: As it is known, antihypertensive drugs are frequently used for the treatment of individuals with high blood pressure all over world. This study aims to precisely determine active substances telmisartan and hydrochlorothiazide, which commercially sold as in market, use ratio spectrum method this purpose. Method: All, solutions ingredients studied were prepared various concentrations....

Journal: :Circulation. Cardiovascular genetics 2012
Yan Gong Caitrin W McDonough Zhiying Wang Wei Hou Rhonda M Cooper-DeHoff Taimour Y Langaee Amber L Beitelshees Arlene B Chapman John G Gums Kent R Bailey Eric Boerwinkle Stephen T Turner Julie A Johnson

BACKGROUND To date, 39 single nucleotide polymorphisms (SNPs) have been associated with blood pressure (BP) or hypertension in genome-wide association studies in whites. Our hypothesis is that the loci/SNPs associated with BP/hypertension are also associated with BP response to antihypertensive drugs. METHODS AND RESULTS We assessed the association of these loci with BP response to atenolol o...

Journal: :Hypertension 2009
Yoshio Matsui Kazuo Eguchi Michael F O'Rourke Joji Ishikawa Hiroshi Miyashita Kazuyuki Shimada Kazuomi Kario

The aim of this study was to compare the effects between calcium channel blockers and diuretics when used in combination with angiotensin II receptor blocker on aortic systolic blood pressure (BP) and brachial ambulatory systolic BP. We conducted a prospective, randomized, open-label, blinded end point study in 207 hypertensive patients (mean age: 68.4 years). Patients received olmesartan monot...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003
Gheun-Ho Kim Ki Young Na So-Young Kim Kwon Wook Joo Yoon Kyu Oh Seoung-Wan Chae Hitoshi Endou Jin Suk Han

BACKGROUND Thiazide and loop diuretics are secreted from the proximal tubule via the organic anion transport system to reach their principal sites of action. Recently, a multispecific organic anion transporter 1 (OAT1) was identified in rat kidney and was localized to the basolateral membrane of the S2 segment in the proximal tubule. We postulated that interactions between thiazide or loop diur...

Journal: :Hypertension 2011
Kenneth A Jamerson Richard Devereux George L Bakris Björn Dahlöf Bertram Pitt Eric J Velazquez Matthew Weir Roxzana Y Kelly Tsushung A Hua Allen Hester Michael A Weber

The combination of benazepril plus amlodipine was shown to be more effective than benazepril plus hydrochlorothiazide in reducing cardiovascular events in the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial. There was a small difference in clinic systolic blood pressure between the treatment arms favoring benazepril plu...

Journal: :Hypertension 2010
Rhonda M Cooper-DeHoff Sheron Wen Amber L Beitelshees Issam Zineh John G Gums Stephen T Turner Yan Gong Karen Hall Vishal Parekh Arlene B Chapman Eric Boerwinkle Julie A Johnson

We assessed adverse metabolic effects of atenolol and hydrochlorothiazide among hypertensive patients with and without abdominal obesity using data from a randomized, open-label study of hypertensive patients without evidence of cardiovascular disease or diabetes mellitus. Intervention included randomization to 25 mg of hydrochlorothiazide or 100 mg of atenolol monotherapy followed by their com...

2010
Monica Doménech Antonio Coca

Hypertension is one of the main risk factors for the development of cardiovascular diseases and the search for new therapeutic strategies aimed at optimizing its control remains an ongoing research and clinical challenge. In recent years, there has been a marked increase in the use of combinations of antihypertensive drugs with complementary mechanisms of action, with the aims of reducing blood...

Journal: :Hypertension 2009
Fang Luo Yibo Wang Xiaojian Wang Kai Sun Xianliang Zhou Rutai Hui

NEDD4L is involved in the regulation of plasma volume and blood pressure by controlling cell surface expression of the kidney epithelial Na(+) channel. Previously, the cryptic splice variant rs4149601(G/A) A allele of NEDD4L, generating isoform I, was estimated to decrease blood pressure by downregulating Na(+) reabsorption. However, a recent functional study showed that isoform I should lead t...

2012
William C. Cushman George L. Bakris William B. White Michael A. Weber Domenic Sica Andrew Roberts Eric Lloyd Stuart Kupfer

Azilsartan medoxomil, an effective, long-acting angiotensin II receptor blocker, is a new treatment for hypertension that is also being developed in fixed-dose combinations with chlorthalidone, a potent, long-acting thiazide-like diuretic. We compared once-daily fixed-dose combinations of azilsartan medoxomil/chlorthalidone force titrated to a high dose of either 40/25 mg or 80/25 mg with a fix...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید